Funds holding BIONEXUS GENE LAB CORP
2 funds declare a position · 0 ETFs and 2 other funds · 6.5K $ · US0906283066
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,368 | 6.5K $ | as of Feb 28, 2026 · Original filing | |
| 2 | Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 3 | 6.5 $ | as of Mar 31, 2026 · Original filing |
Institutional managers
2 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| UBS Group AG | 231 | 495 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 1 | 2 $ | as of Mar 31, 2026 |